"We had a strong first quarter across our global commercial business, driven by substantial growth in the number of patients we're treating with our medicines," CEO Ludwig Hantson said in an earnings news release.Over 100 years of market history shows that the stocks that go on to make the biggest gains tend to have an RS Rating of above 80 in the early stages of their moves.